Freestone Capital Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,987
| Closed | -$539K | – | 449 |
|
|
2022
Q1 | $539K | Sell |
6,987
-1,822
| -21% | -$141K | 0.02% | 331 |
|
|
2021
Q4 | $778K | Buy |
8,809
+353
| +4% | +$31.2K | 0.03% | 262 |
|
|
2021
Q3 | $654K | Sell |
8,456
-788
| -9% | -$60.9K | 0.03% | 257 |
|
|
2021
Q2 | $771K | Sell |
9,244
-301
| -3% | -$25.1K | 0.04% | 236 |
|
|
2021
Q1 | $721K | Buy |
9,545
+490
| +5% | +$37K | 0.04% | 239 |
|
|
2020
Q4 | $794K | Sell |
9,055
-437
| -5% | -$38.3K | 0.05% | 211 |
|
|
2020
Q3 | $722K | Sell |
9,492
-378
| -4% | -$28.8K | 0.05% | 203 |
|
|
2020
Q2 | $1.22K | Buy |
9,870
+895
| +10% | +$110 | 0.01% | 185 |
|
|
2020
Q1 | $758 | Buy |
8,975
+1,490
| +20% | +$126 | 0.02% | 211 |
|
|
2019
Q4 | $633 | Sell |
7,485
-1,331
| -15% | -$113 | 0.01% | 295 |
|
|
2019
Q3 | $594 | Buy |
8,816
+524
| +6% | +$35 | 0.01% | 303 |
|
|
2019
Q2 | $710 | Buy |
8,292
+829
| +11% | +$71 | 0.02% | 262 |
|
|
2019
Q1 | $663K | Buy |
7,463
+3,665
| +96% | +$326K | 0.04% | 252 |
|
|
2018
Q4 | $323K | Buy |
+3,798
| New | +$323K | 0.02% | 332 |
|